Cannabis sativa extracts demonstrate potential to in COVID-19 treatment
By Akshay Kedari  Date: 2020-04-23

Cannabis sativa extracts demonstrate potential to in COVID-19 treatment

The University of Lethbridge, with Swysh, a company focused on cannabinoid R&D and Pathway Rx, a research company focused on developing custom cannabis therapies, are partnering to unravel a specific Cannabis sativa extract that shows potential as an additional treatment for the novel coronavirus.

Dr. Igor Kovalchuks, Chief Executive Officer at Pathway RX and Dr. Olga Kovalchuk, (both are professors at The University of Lethbridge) reportedly said that although one of their most successful cannabis sativa extracts require further validation in an animal model as well as in a large-scale analysis, the study is crucial for the examination of the effects of medical cannabis on coronavirus.

A team of researchers and Kovalchuks recently submitted their paper to a journal for publication. The paper represents extensive research study on the effects of medical cannabis on COVID-19. The manuscript of the paper has been uploaded on Preprints. However, it signifies that the research has not yet been peer reviewed or been published in a journal.

As per sources close to the matter, the study is focused on how different cannabis extracts affect TMPRSS2 and ACE2 proteins. These proteins are rooted into the cellular membrane and are the main gateway for the coronavirus to enter host cells. Used by the researchers, the C. sativa has been analyzed for modulating the levels of these enzymes.

Initial data indicate that 13 cannabis sativa extracts which are high in the anti-inflammatory cannabinoid cannabidiol can modulate ACE2 expression in coronavirus target tissues and may also down-regulate TMPRSS2 proteins. The results establish that these high-cannabinoid C. sativa lines showcase potential to be a safe and useful addition for the treatment of COVID-19.

Estimates suggests that they could be potentially utilized to develop preventative treatments in the form of a throat gargle or mouthwash product for clinical as well as home use.

 

Source credit: https://www.uleth.ca/unews/article/u-l-scientists-develop-new-medical-cannabis-cultivars-show-promise-combatting-covid-19-virus#.XqEcDGYzbcu

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Abcam & Cancer Research UK join forces to accelerate cancer research
Abcam & Cancer Research UK join forces to accelerate cancer research
By Akshay Kedari

Cancer Research UK, one of the world's biggest independent funder of cancer research, has recently joined forces with Abcam plc, a leading developer of life science tools and reagents, to commercialize and develop novel custom antibodie...

Kerbal Space Program unveils new ESA missions simulation update
Kerbal Space Program unveils new ESA missions simulation update
By Akshay Kedari

Kerbal Space Program, a space flight simulator video game, has launches its new Shared Horizons update across the European frontier. Reportedly, this new update would allow players to recreate ESA (European Space Agency) missions to Mercury and to a ...

Google acquires Canadian augmented reality wearables firm North
Google acquires Canadian augmented reality wearables firm North
By Akshay Kedari

In a recent turn of events, a Canada based augmented reality (AR) wearables company North, has reportedly been acquired by Google for an undisclosed valuation. Based on the reports from Globe and Mail, the deal accounted for USD 180 million. For tho...

Librestream raises $24M through CBGF-led Series-D funding round
Librestream raises $24M through CBGF-led Series-D funding round
By Akshay Kedari

Winnipeg based augmented worker enterprise solutions provider, Librestream, has reportedly raised an amount of $24 million through a Series-D funding round led by Canadian Business Growth Fund (CBGF). The company will use the procured funds to boost ...

John Lewis to soon unveil its biomethane gas filling station
John Lewis to soon unveil its biomethane gas filling station
By Akshay Kedari

UK-based retail giant, John Lewis Partnership has recently announced construction of its dedicated biomethane gas filling station in an effort to curb carbon emission. This move is deemed to be a part of the its vision to become carbon neutral across...